Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help ...

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic Leukemia ...

Neurogene (NGNE) announced an update on its ongoing Phase 1/2 open-label clinical trial evaluating NGN-401 gene therapy for the treatment of ...

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help speed up the process of matching potential volunteers to relevant clinical ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

Medable is bringing generative AI into its clinical trial platform in hopes that the tech will reduce the burden of ...